Lopatin Uri A 4
4 · ASSEMBLY BIOSCIENCES, INC. · Filed Sep 7, 2018
Insider Transaction Report
Form 4
Lopatin Uri A
Chief Med. Off., VP Res. Dev.
Transactions
- Sale
Common Stock
2018-09-06$40.01/sh−336$13,442→ 613,611 total - Sale
Common Stock
2018-09-05$40.09/sh−15,204$609,547→ 613,947 total
Holdings
- 5,000(indirect: By Spouse)
Common Stock
Footnotes (5)
- [F1]The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.41, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the price range.
- [F3]Total includes 606,447 shares that are held by the Uri Lopatin Revocable Trust for which the reporting person is the trustee and sole beneficiary. Accordingly, these shares are reported as being held directly by the reporting person.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.02, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the price range.
- [F5]Total includes 606,111 shares that are held by the Uri Lopatin Revocable Trust for which the reporting person is the trustee and sole beneficiary. Accordingly, these shares are reported as being held directly by the reporting person.